What would you do?

[blueblue]

My impression is that folks from the anabolic world are the people who really understand the grey market. They've been dealing with it for a long time. They taught the GLP community how to buy.

Yeah I think there's some truth in that. There are substantial differences between the two worlds (legality, financial incentive to shut it down, etc), but it seems like the glp1 community took some practices from the anabolic world and really advanced things full speed.

 

[Int96]

I had a good experience with Bhavi.

Exporter of Pharmaceutical Tablets & Skin Cream by Bhavi Overseas, Nagpur

Bhavi Overseas - Exporter of Pharmaceutical Tablets, Skin Cream & Eye Drops from Nagpur, Maharashtra, India

www.bhavioverseas.com

Whatsapp +91 95793 03377

 

[Windingroads06]

I thought the claim that Indian pharma is mostly underdosed should be investigated because I purchase from there and am heavily interested in the quality of what I am getting. Some is, of course, but not by much, from what I've seen. The perspective that you might as well get Chinese UGL instead of Indian pharma is foolish, and even dangerous, in my opinion. If you purchase from a reputable Indian pharma manufacturer (like Sun) your chances of getting a highly overdosed tablet is low, but you can see it happen regularly for Chinese UGL. Take a look through the variance testing over at meso sometime and you'll see what I mean.

Let's say your weekly dose of semaglutide is 2.4 mg, but you accidentally took 4.8 mg because your mixture was overdosed. Probably not something you want to do. Same thing with orals.

Moderate under/overdoses of 15-20% are not great, but I'd rather have that than a batch of pills with some of them being highly ovoverdosed.

There seems to be a lack of understanding about why we should test.

Most legit pharmaceuticals are usually precisely measured. If the vial says 50mg Cefazolin and its more or less and the autopsy can prove it, your legal liability goes through the roof.

Grey market vendors don't have that accountability standard. They are happy to underdose or over dose. And the large majority of grey market consumers don't see the problem with inconsistent dosing.